Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

383 Press Releases
DateTitleCompany
10 Feb 16 Pfizer Commends The FDA Advisory Committee’s Vote To Approve Proposed Biosimilar Infliximab, The First Biosimilar Monoclonal Antibody Reviewed, For All Eligible Indications Pfizer Inc.,
Published by
Business Wire
14 Jan 16 Pfizer Acquires Treerly and Its Family of Products from Sirio Pharma Pfizer Inc.,
Published by
Business Wire
08 Jan 16 Pfizer Expands R&D Equity Investment Strategy to Access Early-Stage Scientific Innovations Pfizer Inc.,
Published by
Business Wire
08 Jan 16 Pfizer Enters into Translational Research Collaboration with Adaptive Biotechnologies to Help Advance Novel Immuno-Oncology Solutions Pfizer Inc.,
Published by
Business Wire
05 Jan 16 Pfizer Invites Public to Listen to Webcast of Pfizer and Allergan Discussion at 34th Annual J.P. Morgan Healthcare Conference Pfizer Inc.,
Published by
Business Wire
04 Jan 16 Merck KGaA, Darmstadt, Germany, Pfizer and Syndax Announce Collaboration to Evaluate Combination of Avelumab and Entinostat in Ovarian Cancer Pfizer Inc.,
Published by
Business Wire
22 Dec 15 Pfizer Invites Public To View And Listen To Webcast Of February 2 Conference Call With Analysts Pfizer Inc.,
Published by
Business Wire
21 Dec 15 Pfizer Reports Top Line Results from a Phase 3 Study Evaluating Desvenlafaxine Succinate Sustained-Release Formulation in Pediatric Patients with Major Depressive Disorder Pfizer Inc.,
Published by
Business Wire
14 Dec 15 Pfizer Declares First-Quarter 2016 Dividend Pfizer Inc.,
Published by
Business Wire
08 Dec 15 Pfizer Awards More Than $4 Million in Grants to Further Clinical Research in Advanced Breast Cancer for 2015 Pfizer Inc.,
Published by
Business Wire
25 Nov 15 Pfizer Reports Top-Line Results from a Phase 3 Study of LYRICA® (pregabalin) Capsules CV in Adults with Post-Traumatic Peripheral Neuropathic Pain Pfizer Inc.,
Published by
Business Wire
25 Nov 15 Merck KGaA, Darmstadt, Germany, and Pfizer Receive Positive Opinion for Orphan Drug Designation for Avelumab in Merkel Cell Carcinoma from EMA Committee for Orphan Medicinal Products Pfizer Inc.,
Published by
Business Wire
18 Nov 15 Pfizer Reports Positive Topline Results from Phase 3 Trial Comparing XALKORI® (crizotinib) to Chemotherapy in Previously Untreated East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) Pfizer Inc.,
Published by
Business Wire
18 Nov 15 Merck KGaA, Darmstadt, Germany, and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma Pfizer Inc.,
Published by
Business Wire
05 Nov 15 Pfizer Expands its Patient Assistance Program, Doubling the Income Eligibility Limit to Benefit Even More Patients Taking Pfizer Medicines  Pfizer Inc.,
Published by
Business Wire
04 Nov 15 Merck KGaA, Darmstadt, Germany, and Pfizer Announce Initiation of Phase III First-Line Trial of Avelumab in Patients with Recurrent or Stage IV Non-Small Cell Lung Cancer Pfizer Inc.,
Published by
Business Wire
31 Oct 15 Pfizer Inc. Announcement under Rule 2.10 of the Irish Takeover Rules – Relevant Securities in Issue Pfizer Inc.,
Published by
Business Wire
29 Oct 15 Pfizer Announces Collaboration with GSK on Next-Generation Design of Portable, Continuous, Miniature and Modular (PCMM) Oral Solid Dose Development and Manufacturing Units Pfizer Inc.,
Published by
Business Wire
01 Oct 15 Pfizer Partners with Breast Cancer Leaders to Chronicle the Lives of Women with Metastatic Breast Cancer through the Lenses of Prominent Photographers Pfizer Inc.,
Published by
Business Wire
24 Aug 15 Pfizer Receives Clearance from U.S. Federal Trade Commission for Hospira Acquisition Pfizer Inc.,
Published by
Business Wire
03 Sep 15 Pfizer Completes Acquisition of Hospira Pfizer Inc.,
Published by
Business Wire
15 Sep 15 Pfizer Invites Public to View and Listen to Webcast of October 27 Conference Call with Analysts Pfizer Inc.,
Published by
Business Wire
24 Sep 15 Pfizer’s Sayana® Press Becomes First Injectable Contraceptive In The United Kingdom Available For Administration By Self-Injection Pfizer Inc.,
Published by
Business Wire
25 Sep 15 Pfizer Declares 28-Cent Fourth-Quarter 2015 Dividend Pfizer Inc.,
Published by
Business Wire
02 Oct 15 Pfizer Inc. Announces Final Results of Exchange Offers Pfizer Inc.,
Published by
Business Wire
18 Sep 15 Pfizer Inc. Announces Results of Early Tenders and Consents in Exchange Offers Pfizer Inc.,
Published by
Business Wire
04 Sep 15 Pfizer Inc. Commences Exchange Offers for Hospira Notes Pfizer Inc.,
Published by
Business Wire
01 Oct 15 Pfizer Completes Acquisition Of Nimenrix And Mencevax From GlaxoSmithKline Pfizer Inc.,
Published by
Business Wire
14 Oct 15 Pfizer Receives Complete Response Letter from FDA for Oral XELJANZ® (tofacitinib citrate) Supplemental New Drug Application for Moderate to Severe Chronic Plaque Psoriasis Pfizer Inc.,
Published by
Business Wire
09 Oct 15 Pfizer’s Phase 2 Study Demonstrates Safety, Tolerability and Immunogenicity of TRUMENBA® When Coadministered with Meningococcal A, C, Y and W-135 Polysaccharide Conjugate (MCV4) and Tetanus, Diphtheria and Pertussis (Tdap) Vaccines in Adolescents Pfizer Inc.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.